• 熔點(diǎn)： 223-225°C

• 沸點(diǎn)： 948.5 °C at 760 mmHg

• 比旋光度： D15 -87.09° (in pyridine)

• 外觀： 淡黃色針狀結(jié)晶粉末

• 溶解性： DMSO：100mg/ml（超聲）

• 儲(chǔ)存條件： 2-8℃

• 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

• 100. [4.4] Chen Yangfeng et al."In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb."Frontiers in Pharmacology.2024 Jul;15:

• 99. [IF=0] Huiling Liu et al."High-strength double-network silk fibroin based hydrogel loaded with Icariin and BMSCs to inhibit osteoclasts and promote osteogenic differentiation to enhance bone repair."Biomaterials Advances".2024 Apr;:213856

• 98. [IF=1.7] Luo Wei et al."Icariin ameliorates viral myocarditis by inhibiting TLR4-mediated ferroptosis."Asian Pacific Journal of Tropical Biomedicine".2024 Mar;14(3):106

• 97. [IF=6] Dong Xie et al."Pharmacodynamic material basis and mechanism of Tenghuang Jiangu Wan on osteoarthritis using UPLC-Q-TOF-MS integrated with target network pharmacology."Arabian Journal of Chemistry".2024 Apr;17:105711

• 96. [IF=5.8] Zhao Mei et al."Icariin exerts anti-tumor activity by inducing autophagy via AMPK/mTOR/ULK1 pathway in triple-negative breast cancer."Cancer Cell International".2024 Dec;24(1):1-15

• 95. [IF=7.9] Yankai Dong et al."Effect of icariin on depressive behaviour in rat pups. Evidences for its mechanism of action by integrating network pharmacology, metabolomics and gut microbiota composition."PHYTOMEDICINE".2024 Apr;126:155422

• 94. [IF=5.4] Xinying Fu et al."Guhan Yangsheng Jing mitigates hippocampal neuronal pyroptotic injury and magnifies learning and memory capabilities in sleep deprived mice via the NLRP3/Caspase1/GSDMD signaling pathway."JOURNAL OF ETHNOPHARMACOLOGY".2024 Feb;:117972

• 93. [IF=8.4] Ting An et al."De novo biosynthesis of anticarcinogenic icariin in engineered yeast."METABOLIC ENGINEERING.2023 Nov;80:207

• 92. [IF=5.8] Xu Wenjing et al."Icariin-Curcumol promotes docetaxel sensitivity in prostate cancer through modulation of the PI3K-Akt signaling pathway and the Warburg effect."Cancer Cell International.10.1186/s12935-023-03042-1

• 91. [IF=8.2] Shaorong Li et al."Dual-functional 3D-printed porous bioactive scaffold enhanced bone repair by promoting osteogenesis and angiogenesis."Materials Today Bio.2024 Feb;24:100943

• 90. [IF=4.7] Xu Zhang et al."Rhein: A potent immunomodulator empowering largemouth bass against MSRV infection."FISH & SHELLFISH IMMUNOLOGY.2024 Jan;144:109284

• 89. [IF=1.7] Zhouyi Zhang et al."Revealing the differences in phenolics in different parts of Taraxacum mongolicum using UPLC-MS/MS."Phytochemistry Letters.2023 Aug;56:13

• 88. [IF=5.572] Zhen Zhao et al."An integrated strategy combining network toxicology and feature-based molecular networking for exploring hepatotoxic constituents and mechanism of Epimedii Folium-induced hepatotoxicity in vitro."FOOD AND CHEMICAL TOXICOLOGY.2023 Jun;176:

• 87. [IF=6.208] Jiaqi Zhang et al."The Effect of Epimedium Isopentenyl Flavonoids on the Broiler Gut Health Using Microbiomic and Metabolomic Analyses."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2023 Jan;24(8):7646

• 86. [9.273] Jia Zeng et al."Bone Mesenchymal Stem Cell-derived Exosomes Involved Co-delivery and Synergism Effect with Icariin via Mussel-inspired Multifunctional Hydrogel for Cartilage Protection."Asian Journal of Pharmaceutical Sciences.2023 Mar;:100799

• 85. [2.626] Ma, Rui-jiao et al."Kunxian Capsule Extract Inhibits Angiogenesis in Zebrafish Embryos via PI3K/AKT-MAPK-VEGF Pathway."Chinese Journal of Integrative Medicine.2022 Dec;:1-9

• 84. [6.438] Wenjing Xu et al."Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7/m-TOR/SREBP1 pathway on prostate cancer."BIOFACTORS.2022 Dec;:

• 83. [7.31] Mengxia Wang et al."Neuroprotective Mechanism of Icariin on Hypoxic Ischemic Brain Damage in Neonatal Mice."Oxidative Medicine and Cellular Longevity.2022 Nov 15;2022:1330928

• 82. [IF=1.698] Jinyan Wu et al."Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS."International Journal of Analytical Chemistry.2022 Oct 15;2022:142380

• 81. [IF=3.571] Yuhao Zhang et al."A novel strategy integrating gas phase fractionation with staggered mass range and LC-MS/MS molecular network for comprehensive metabolites profiling of Gui Ling Ji in rats."JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS.2023 Jan;222

• 80. [IF=5.738] Fu Yanjin et al."Icariin attenuates the tumor growth by targeting miR-1-3p/TNKS2/Wnt/β-catenin signaling axis in ovarian cancer."Frontiers in Oncology.2022 Sep;0:4742

• 79. [IF=6.208] Pan Wang et al."Discovery of Flavonoids as Novel Inhibitors of ATP Citrate Lyase: Structure–Activity Relationship and Inhibition Profiles."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(18):10747

• 78. [IF=5.895] Fang Liu et al."Co-Immobilizing Two Glycosidases Based on Cross-Linked Enzyme Aggregates to Enhance Enzymatic Properties for Achieving High Titer Icaritin Biosynthesis."JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY.2022;XXXX(XXX):XXX-XXX

• 77. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231

• 76. [IF=6.064] Jia-Jun Huang et al."Computer-Aided Design of α-L-Rhamnosidase to Increase the Synthesis Efficiency of Icariside I."Frontiers in Bioengineering and Biotechnology.2022; 10: 926829

• 75. [IF=2.63] Li Hangchao et al."Bushen Jianpi Quyu Formula Alleviates Myelosuppression of an Immune-Mediated Aplastic Anemia Mouse Model via Inhibiting Expression of the PI3K/AKT/NF-κB Signaling Pathway."Evidence-based Complementary and Alternative Medicine. 2022;2022:

• 74. [IF=6.53] Pan Sun et al."Jiangu granule ameliorated OVX rats bone loss by modulating gut microbiota-SCFAs-Treg/Th17 axis."BIOMEDICINE & PHARMACOTHERAPY. 2022 Jun;150:112975

• 73. [IF=5.34] Dong Shao et al."Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology."PHYTOMEDICINE. 2022 Jul;102:154177

• 72. [IF=3.935] Junmao Li et al."Comprehensive chemical profiling of the flowers of Citrus aurantium L. var. amara Engl. and uncovering the active ingredients of lipid lowering."J Pharmaceut Biomed. 2022 Mar;211:114621

• 71. [IF=1.672] Yang Lihong et al."Bioactive molecule Icariin inhibited proliferation while enhanced apoptosis and autophagy of rat airway smooth muscle cells in vitro."Cytotechnology. 2019 Dec;71(6):1109-1120

• 70. [IF=1.902] Ting Zhang et al."The influence of essential oils from ZhaLi NuSi Prescription on the pharmacokinetics of its non-volatile components in normal rats."Biomedical Chromatography. 2021 Oct 21

• 69. [IF=1.986] Yang Du et al."Investigation of labile protein-ligand interactions by native electrospray ionization mass spectrometry."Int J Mass Spectrom. 2021 Apr;462:116524

• 68. [IF=2.447] Ling Sun et al."Icariin inhibits oral squamous cell carcinoma cell proliferation and induces apoptosis via inhibiting the NF?κB and PI3K/AKT pathways."Exp Ther Med. 2021 Sep;22(3):1-7

• 67. [IF=2.984] Xiao-Hua Yang et al."Flavonoids from Epimedium pubescens: extraction and mechanism, antioxidant capacity and effects on CAT and GSH-Px of Drosophila melanogaster."Peerj. 2020 Jan;8:e8361

• 66. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950

• 65. [IF=3.361] Yuhao Zhang et al."An integrated approach for structural characterization of Gui Ling Ji by traveling wave ion mobility mass spectrometry and molecular network."Rsc Adv. 2021 Apr;11(26):15546-15556

• 64. [IF=3.645] Junfeng Li et al."An LC-MS/MS method for simultaneous quantification of 11 components of Xian-Xiong-Gu-Kang in the plasma of osteoarthritic rats and pharmacokinetic analysis."J Sep Sci. 2021 Sep;44(18):3386-3397

• 63. [IF=3.757] Congyan Liu et al."Enhanced hydrolysis and antitumor efficacy of Epimedium flavonoids mediated by immobilized snailase on silica."Process Biochem. 2019 Nov;86:80

• 62. [IF=3.765] Shun Liu et al."Simultaneous determination of seven effective components in Shenkui Tongmai granules based on UHPLC-MS/MS."J Pharm Pharmacol. 2021 Apr;73(6):758-766

• 61. [IF=4.36] Kun Shi et al."Epimedii Folium and Curculiginis Rhizoma ameliorate lipopolysaccharides-induced cognitive impairment by regulating the TREM2 signaling pathway."J Ethnopharmacol. 2022 Feb;284:114766

• 60. [IF=4.411] Zhenxian Qin et al."A Widely Metabolomic Analysis Revealed Metabolic Alterations of Epimedium Pubescens Leaves at Different Growth Stages."Molecules. 2020 Jan;25(1):137

• 59. [IF=4.432] Luya Pu et al."Icariin arrests cell cycle progression and induces cell apoptosis through the mitochondrial pathway in human fibroblast-like synoviocytes."Eur J Pharmacol. 2021 Dec;912:174585

• 58. [IF=5.34] Liping Zhang et al."Cardioprotective effect of icariin against myocardial fibrosis and its molecular mechanism in diabetic cardiomyopathy based on network pharmacology: Role of ICA in DCM."Phytomedicine. 2021 Oct;91:153607

• 57. [IF=2.419] Lu Wang et al."Characterization of interaction property of multi-components in Gardenia jasminoides with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry."Rapid Communications In Mass Spectrometry. 2016 Au

• 56. [IF=3.935] Tong Wang et al."Metabolic profiling of icariin in rat feces, urine, bile and plasma after oral administration using ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry."J Pharmaceut Biomed. 2019 May;168:155

• 55. [IF=4.411] Tao Cheng et al."Comparative Pharmacokinetics Study of Icariin and Icariside II in Rats."Molecules. 2015 Dec;20(12):21274-21286

• 54. [IF=4.545] Yan-dan Zhou et al."Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway."Biomed Pharmacother. 2019 Jan;109:2309

• 53. [IF=5.64] Wu Dousheng et al."Oleanolic Acid Induces the Type III Secretion System of Ralstonia solanacearum."Front Microbiol. 2015 Dec;0:1466

• 52. [IF=6.529] Congyan Liu et al."Icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats."Biomed Pharmacother. 2017 Oct;94:1048

• 51. Cheng, Tao, et al. "Comparative pharmacokinetics study of icariin and icariside II in rats." Molecules 20.12 (2015): 21274-21286.https://doi.org/10.3390/molecules201219763

• 50. Yang, Lihong, et al. "Bioactive molecule Icariin inhibited proliferation while enhanced apoptosis and autophagy of rat airway smooth muscle cells in vitro." Cytotechnology 71.6 (2019): 1109-1120.https://doi.org/10.1007/s10616-019-00348-9

• 49. Liu, Congyan, et al. "Icariin combined with snailase shows improved intestinal hydrolysis and absorption in osteoporosis rats."?Biomedicine & Pharmacotherapy?94 (2017): 1048-1056.https://doi.org/10.1016/j.biopha.2017.07.163

• 48. Jia, Xiaohe, et al. "Design, preparation, surface recognition properties, and characteristics of icariin molecularly imprinted polymers." Cogent Chemistry 1.1 (2015): 1059597.

• 47. Wang, Lu, et al. "Characterization of interaction property of multi‐components in Gardenia jasminoides with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry." Rapid Communications in Mass Spectrometry 30 (2

• 46. Wang, Lu, et al. "Characterization of interaction property of multi‐components in Gardenia jasminoides with aldose reductase by microdialysis combined with liquid chromatography coupled to mass spectrometry." Rapid Communications in Mass Spectrometry 30 (2

• 45. 黃楷迪,劉敬霞,牛陽(yáng),馬學(xué)琴,張婷,卜凡淑,任慧,郭盛,錢大瑋,段金廒.回藥扎里奴思方UPLC指紋圖譜結(jié)合多成分含量測(cè)定的質(zhì)控方法研究[J].南京中醫(yī)藥大學(xué)學(xué)報(bào),2021,37(01):77-82.

• 44. 蘭海,劉欣妍,余玲,莫諾蘭,張燕,郭子右,吳清.大孔樹脂純化淫羊藿中朝藿定與淫羊藿苷工藝研究[J].中草藥,2020,51(17):4473-4481.

• 43. 劉聰燕,李瑞云,馬程遙,劉玉萍,瞿鼎,李曉琦,陳彥.殼聚糖交聯(lián)介孔二氧化硅固定化β-葡萄糖苷酶生物轉(zhuǎn)化淫羊藿苷研究[J].中草藥,2021,52(03):685-691.

• 42. 武通,陳東寧,許占江.基于VEGF/VEGFR-2信號(hào)通路研究淫羊藿苷促進(jìn)大鼠脛骨干骨折愈合的作用機(jī)制[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào),2021,45(03):282-288+293.

• 41. 何俊慧,韋潔,李冬梅,何飛,陸國(guó)壽,韋冬梅,李懿,趙成堅(jiān),韋桂寧,李力.基于TLR4/NF-κB通路探討蛤蚧提取物對(duì)利血平誘導(dǎo)抑郁大鼠神經(jīng)炎癥的影響[J].中國(guó)實(shí)驗(yàn)方劑學(xué)雜志,2021,27(09):56-62.

• 40. 范小龍,陳冉,吳婉琴,劉國(guó)姣,黃坤,江豐.液相色譜串聯(lián)質(zhì)譜法測(cè)定食品中淫羊藿苷等20種功能成分[J].食品與機(jī)械,2021,37(01):86-93+98.

• 39. 李琦,孫貴才.淫羊藿苷對(duì)骨髓間充質(zhì)干細(xì)胞鐵死亡及向心肌樣細(xì)胞分化的影響[J].中國(guó)組織工程研究,2021,25(13):1988-1992.

• 38. 彭靜, 馬益華, 陳彥,等. 固定化蝸牛酶同時(shí)生物轉(zhuǎn)化淫羊藿中4種黃酮苷[J]. 中成藥, 2016, 38(9):1984-1990.

• 37. 張初瑜 陳素紅 吳素香. 一測(cè)多評(píng)法測(cè)定復(fù)方人參片中的8種苷類成分[J]. 中國(guó)現(xiàn)代應(yīng)用藥學(xué) 2018 35(05):90-96.

• 36. 高霞, 陳彥, 王瑩,等. 糊精濕法制粒對(duì)淫羊藿總黃酮酶解的影響[J]. 中成藥, 2014, 36(007):1392-1397.

• 35. 高霞, 劉璇, 陳彥,等. 淫羊藿總黃酮的生物轉(zhuǎn)化過(guò)程分析[J]. 中國(guó)中藥雜志, 2013, 38(23):4079.

• 34. 劉聰燕, 高霞, 陳彥,等. 淫羊藿總黃酮在骨質(zhì)疏松大鼠體內(nèi)的藥動(dòng)學(xué)行為[J]. 中成藥, 2017, 39(008):1595-1600.

• 33. 劉聰燕, 高霞, 黃萌萌,等. 淫羊藿總黃酮仿生酶解腸溶膠囊的制備及評(píng)價(jià)[J]. 中草藥, 2016(20).

• 32. 張燕. 大孔吸附樹脂分離純化淫羊藿EF5黃酮[J]. 北方藥學(xué), 2015, 000(011):11-13.

• 31. 劉聰燕 高霞 陳彥 等. 仿生酶解腸溶膠囊提高淫羊藿總黃酮口服生物利用度的可行性研究[J]. 中國(guó)醫(yī)藥工業(yè)雜志 2016(9期):1158-1164.

• 30. 楊成梓 范興 包俠萍 等. HPLC同時(shí)測(cè)定芪骨膠囊中5種成分的含量[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志 2015 021(016):60-63.

• 29. 李婧,王英哲,劉玉翠,景志賢,閆莉,郭俊杰,姜大成,肖井雷.地理環(huán)境因子對(duì)朝鮮淫羊藿黃酮類成分空間分布影響的探測(cè)分析[J].中國(guó)中藥雜志,2019,44(24):5368-5374.

• 28. 王瑩 高霞 陳彥 等. 卡波姆對(duì)淫羊藿總黃酮酶解效果的影響[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志 2014 20(009):1-5.

• 27. 范興, 楊成梓, 包俠萍,等. 芪骨膠囊HPLC指紋圖譜研究[J]. 中草藥, 2014, 045(009):1257-1261.

• 26. 涂艷, 熊莉娜, 柳湘潔,等. 淫羊藿苷對(duì)成骨細(xì)胞成骨分化的影響及Wnt/-catenin信號(hào)系統(tǒng)的關(guān)系研究[J]. 中國(guó)中醫(yī)急癥, 2017, 26(003):448-450.

• 25. 王藝璇 李海濤 劉順 等. 參葵通脈顆粒的質(zhì)量標(biāo)準(zhǔn)研究[J]. 中藥新藥與臨床藥理 2020年31卷8期 984-989頁(yè) ISTIC PKU CSCD CA 2020.

• 24. 郭雙雙 鄭芳芳 可叢雪 等. 乳酸片球菌AS1.2696來(lái)源的α-L-鼠李糖苷酶酶學(xué)性質(zhì)分析[J]. 食品科學(xué) 2019 040(004):160-169.

• 23. 程素盼 張敏敏 梁琰 等. HPLC-DAD-ESI-TOF/MS法分析安神補(bǔ)腦液中化學(xué)成分[J]. 中成藥 2019 041(004):743-748.

• 22. 趙巖, 侯瑩瑩, 唐國(guó)勝,等. 炮制前后淫羊藿不同提取物對(duì)ACE、α-葡萄糖苷酶的抑制活性及對(duì)亞硝酸根的清除活性研究[J]. 藥物分析雜志, 2015(8期):1329-1334.

• 21. 劉玉萍, 丁學(xué)芳, 黃萌萌,等. 淫羊藿苷在不同骨質(zhì)疏松大鼠模型中腸道吸收代謝研究[J]. 中國(guó)中藥雜志, 2016(13):2532-2537.

• 20. 李瑞云 劉聰燕 許婷 等. 交聯(lián)納米SiO_2固定化蝸牛酶的制備表征及轉(zhuǎn)化淫羊藿苷研究[J]. 中草藥 2019 v.50;No.655(20):57-63.

• 19. 洪雅丹 張凌風(fēng) 潘娉娉 等. HPLC法同時(shí)測(cè)定淫羊藿-骨碎補(bǔ)藥對(duì)中7種成分[J]. 中成藥 2019 041(006):1316-1321.

• 18. 楊軼舜 張彤 丁越 等. 3種淫羊藿苷次生產(chǎn)物的制備及HPLC測(cè)定[J]. 中成藥 2020 042(003):779-782.

• 17. 何玉瓊, 趙璐, 沈燚,等. 淫羊藿苷對(duì)鐵超載模型小鼠骨代謝的影響[J]. 藥學(xué)學(xué)報(bào), 2018(7).

• 16. 楊芬, 劉彥禮, 閆巖,等. 淫羊藿苷對(duì)經(jīng)血源性子宮內(nèi)膜干細(xì)胞成心肌樣細(xì)胞分化的影響[J]. 中國(guó)細(xì)胞生物學(xué)學(xué)報(bào), 2016(11):1373-1381.

• 15. 鞠靜, 譚人千, 鐘勇,等. 淫羊藿苷對(duì)氣管切開模型大鼠早期β-防御素-2和T細(xì)胞亞群的影響[J]. 中南大學(xué)學(xué)報(bào):醫(yī)學(xué)版, 2020(1):1-7.

• 14. 鄧淑蓉, 潘宇政, 彭玲玲,等. 淫羊藿苷對(duì)氣管切開插管大鼠肺部肥大細(xì)胞活性及炎性反應(yīng)的影響[J]. 中華中醫(yī)藥雜志, 2018, 033(004):1594-1597.

• 13. 郭艷霞. 淫羊藿苷對(duì)去卵巢大鼠骨質(zhì)疏松癥的保護(hù)機(jī)制研究[J]. 四川中醫(yī), 2017, 035(007):63-65.

• 12. 朱彤彤, 黃連弟, 李俊瑋,等. 淫羊藿苷對(duì)去卵巢大鼠骨質(zhì)疏松癥的保護(hù)作用及其機(jī)制[J]. 吉林大學(xué)學(xué)報(bào)(醫(yī)學(xué)版), 2016, 42(005):915-919.

• 11. 周勇, 劉晶, 陳剛. 淫羊藿苷對(duì)D-半乳糖誘導(dǎo)的腦衰老模型小鼠皮層線粒體自噬的影響[J]. 中華中醫(yī)藥雜志, 2019, v.34(12):156-160.

• 10. 周勇,劉晶,陳剛.淫羊藿苷對(duì)D-半乳糖誘導(dǎo)的腦衰老模型小鼠p53/p21信號(hào)通路的影響[J].中華中醫(yī)藥學(xué)刊,2019,37(09):2159-2162+2316.

• 9. 鞠靜, 彭玲玲, 潘宇政,等. 淫羊藿苷及寶藿苷I對(duì)氣管切開模型大鼠肺組織病理學(xué)及炎癥因子的影響[J]. 中國(guó)實(shí)驗(yàn)動(dòng)物學(xué)報(bào), 2019, 27(3).

• 8. 徐永明, 徐宏光, 張曉玲,等. 淫羊藿素藥物在終板軟骨細(xì)胞退變中的保護(hù)作用研究[J]. 赤峰學(xué)院學(xué)報(bào)(自然版), 2016(16):54-57.

• 7. 林思文, 李雪芹, 劉素云,等. 淫羊藿素聯(lián)合阿霉素對(duì)人骨肉瘤MG-63細(xì)胞抑制作用的體外研究[J]. 中國(guó)中西醫(yī)結(jié)合雜志, 2016(36):0729-734.

• 6. 劉玉亮, 梁廣勝, 魏強(qiáng)強(qiáng),等. 淫羊藿總黃酮及淫羊藿素體外抗骨肉瘤的研究[J]. 中成藥, 2013, 35(010):2072-2077.

• 5. 彭靜, 馬益華, 陳彥,等. 微乳化-凝膠法制備微球固定化蝸牛酶并生物轉(zhuǎn)化淫羊藿苷研究[J]. 中草藥, 2015, 46(22):3326-3332.

• 4. 彭靜, 馬益華, 陳彥,等. 固定化β-葡萄糖苷酶和蝸牛酶生物轉(zhuǎn)化淫羊藿苷效率的比較研究[J]. 藥學(xué)學(xué)報(bào), 2015(12期):1652-1659.

• 3. 查琳 趙巖 祝洪艷 等. 人參莖葉總皂苷脂質(zhì)體與水溶液在大鼠體內(nèi)的血藥濃度及藥代動(dòng)力學(xué)參數(shù)對(duì)比分析[J]. 中國(guó)中藥雜志 2017(10).

• 2. 謝媛媛 彭靈 蘇加坤 等. 中藥淫羊藿薄層色譜鑒別方法的建立[J]. 中藥與臨床 2017(04):20-24.

• 1. 侯劍偉 丁越 張彤 等. HPLC-DAD法同時(shí)測(cè)定調(diào)更湯中3個(gè)活性成分[J]. 中成藥 2014 36(7):1454-1457.

輸入產(chǎn)品批號(hào)：

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系，公式為：

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *